AEON Biopharma Inc (AEON)
AMEX
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -9.877 | 5.921 | 3.587 | 16.795 |
Return on Equity (%) | -38.095 | -97.002 | -75.701 | -29.599 |
Return on Invested Capital (%) | 13.333 | 22.637 | 26.758 | -36.177 |
Operating Margin (%) | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.003 | 37.546 | 3.899 | -2.784 |
Earnings Per Share | -0.001 | 1.189 | 0.145 | 0.437 |
Cash Per Share | N/A | 0.072 | 0.001 | 0.094 |
Working Capital Per Share | -0.009 | N/A | -0.055 | -0.124 |
Operating Profit Per Share | N/A | N/A | N/A | 0.96 |
EBIT Per Share | -0.001 | 1.189 | 0.157 | 0.437 |
EBITDA Per Share | -0.001 | 1.189 | 0.157 | 0.437 |
Free Cash Flow Per Share | -0.001 | 1.189 | 0.145 | 0.437 |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Shares Outstanding | N/A | N/A | N/A | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |||||
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 25.96M |
Price to Earnings Ratio | 1.05 |
Price to Sales Ratio | 0.48 |
Price to Cash Ratio | 4.88 |
Price to Book Ratio | -0.16 |
Dividend Yield | - |
Shares Outstanding | 39.97M |
Average Volume (1 week) | 135.75k |
Average Volume (1 Month) | 300.52k |
52 Week Change | -89.36% |
52 Week High | 17.17 |
52 Week Low | 0.5206 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.